Alofanib

DB20918InvestigationalSmall molecule

Alofanib is a small molecule drug. The usage of the INN stem '-anib' in the name indicates that Alofanib is a angiogenesis inhibitor. Alofanib is under investigation in clinical trial... Alofanib is under investigation in clinical trial NCT04071184 (Study of Alofanib in Patients With Metastatic Gastric Cancer).

Chemical structure of Alofanib
Formula / weight
C19H15N3O6S · 413.4 g/mol (avg)

Resolves to

Compound
UNIILQX7RFK8MZCAS1612888-66-0ChEMBLCHEMBL4594436ChEBI757923PubChem86280646
Structure
InChIKeyQUQGQIASFYWKAB-UHFFFAOYSA-NSMILESCC1=C(C=C(NS(=O)(=O)C2=CC=CC(=C2)C(O)=O)C(=C1)[N+]([O-])=O)C1=CN=CC=C1
Targets
P21802FGFR2

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Alofanib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In